Primary cultivation: Factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Bratschi, Martin W ^a,b   Bolz, Miriam ^a,b   Grize, Leticia ^a,b   Kerber, Sarah ^a,b   Minyem, Jacques C ^a,c   Um Boock, Alphonse ^c   Yeboah Manu, Dorothy ^d   Ruf, Marie Thérèse ^a,b   Pluschke, Gerd ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c FAIRMED Africa Regional Office   (Cameroon)

^d University of Ghana   (Ghana)

Author keywords

Buruli ulcer; Long turnover time; Mycobacterium ulcerans; Primary cultivation

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; BURULI ULCER; CAMEROON; CULTURE MEDIUM; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; INOCULATION; INSTRUMENT STERILIZATION; MICROBIAL CONTAMINATION; MYCOBACTERIUM ULCERANS; NONHUMAN; SKIN EXAMINATION; SKIN SWAB; TRANSPORT MEDIUM; TURNOVER TIME; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MICROBIOLOGY; PROCEDURES; TIME;

CULTURE MEDIUM;

BURULI ULCER; CAMEROON; CULTURE MEDIA; HUMANS; MYCOBACTERIUM ULCERANS; SPECIMEN HANDLING; TIME FACTORS;

EID: 84924287213     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0636-7     Document Type: Article

References (20)

1. Merritt RW, Walker ED, Small PLC, Wallace JR, Johnson PDR, Benbow ME, Boakye DA: Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis 2010, 4:e911.
2. Walsh DS, Portaels F, Meyers WM: Buruli ulcer: advances in understanding Mycobacterium ulcerans infection. Dermatol Clin 2011, 29:1-8.
3. WHO | Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer).[ http://www.who.int/buruli/information/antibiotics/en/index.html ]
4. Buruli ulcer: diagnosis of Mycobacterium ulcerans disease: a manual for health care providers. In Edited by Portaels F, Johnson P, Meyers WM.[ http://apps.who.int/iris/handle/10665/67000 ]
5. Yeboah-Manu D, Bodmer T, Mensah-Quainoo E, Owusu S, Ofori-Adjei D, Pluschke G: Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens. J Clin Microbiol 2004, 42:5875-5876.
6. Portaels F, Agular J, Fissette K, Fonteyne PA, De Beenhouwer H, de Rijk P, Guédénon A, Lemans R, Steunou C, Zinsou C, Dumonceau JM, Meyers WM: Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol 1997, 35:1097-1100.
7. Röltgen K, Qi W, Ruf M-T, Mensah-Quainoo E, Pidot SJ, Seemann T, Stinear TP, Käser M, Yeboah-Manu D, Pluschke G: Single nucleotide polymorphism typing of Mycobacterium ulcerans reveals focal transmission of buruli ulcer in a highly endemic region of Ghana. PLoS Negl Trop Dis 2010, 4:e751.
8. Beissner M, Awua-Boateng N-Y, Thompson W, Nienhuis WA, Klutse E, Agbenorku P, Nitschke J, Herbinger K-H, Siegmund V, Fleischmann E, Adjei O, Fleischer B, van der Werf TS, Loscher T, Bretzel G: A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana. Am J Trop Med Hyg 2010, 83:1059-1065.
9. Petroff SA: A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and feces. J Exp Med 1915, 21:38-42.
10. Palomino JC, Portaels F: Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol 1998, 36:402-408.
11. Eddyani M, Debacker M, Martin A, Aguiar J, Johnson CR, Uwizeye C, Fissette K, Portaels F: Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol 2008, 46:69-72.
12. Eddyani M, Fraga AG, Schmitt F, Uwizeye C, Fissette K, Johnson C, Aguiar J, Sopoh G, Barogui Y, Meyers WM, Pedrosa J, Portaels F: Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer. J Clin Microbiol 2009, 47:1700-1704.
13. Yeboah-Manu D, Danso E, Ampah K, Asante-Poku A, Nakobu Z, Pluschke G: Isolation of Mycobacterium ulcerans from swab and fine-needle-aspiration specimens. J Clin Microbiol 2011, 49:1997-1999.
14. Bratschi MW, Bolz M, Minyem JC, Grize L, Wantong FG, Kerber S, Njih Tabah E, Ruf M-T, Mou F, Noumen D, Um Boock A, Pluschke G: Geographic distribution, age pattern and sites of lesions in a cohort of buruli ulcer patients from the mapé basin of cameroon. PLoS Negl Trop Dis 2013, 7:e2252.
15. Lavender CJ, Fyfe JAM: Direct detection of Mycobacterium ulcerans in clinical specimens and environmental samples. Methods Mol Biol Clifton NJ 2013, 943:201-216.
16. Beissner M, Herbinger K-H, Bretzel G: Laboratory diagnosis of Buruli ulcer disease. Future Microbiol 2010, 5:363-370.
17. Mensah-Quainoo E, Yeboah-Manu D, Asebi C, Patafuor F, Ofori-Adjei D, Junghanss T, Pluschke G: Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases. Trop Med Int Health TM IH 2008, 13:191-198.
18. Williamson H, Phillips R, Sarfo S, Wansbrough-Jones M, Small P: Genetic diversity of PCR-positive, culture-negative and culture-positive mycobacterium ulcerans isolated from buruli ulcer patients in Ghana. PLoS One 2014, 9:e88007.
19. Yeboah-Manu D, Kpeli GS, Ruf M-T, Asan-Ampah K, Quenin-Fosu K, Owusu-Mireku E, Paintsil A, Lamptey I, Anku B, Kwakye-Maclean C, Newman M, Pluschke G: Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin. PLoS Negl Trop Dis 2013, 7:e2191.
20. Demangel C, Stinear TP, Cole ST: Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol 2009, 7:50-60.